The Association of Salvia divinorum and Psychotic Disorders: A Review of the Literature and Case Series

Journal of Psychoactive Drugs
Joseph El-Khoury, Nayiri Sahakian

Abstract

The association of substance abuse and psychotic disorders is of interest to clinicians, academics, and lawmakers. Commonly abused substances, such as cannabis, cocaine, amphetamines, and alcohol, have all been associated with substance-induced psychosis. Hallucinogens can induce desired psychedelic effects and undesirable psychomimetic reactions. These are usually transient and resolve once the duration of action is over. Sometimes, these effects persist, causing distress and requiring intervention. This article focuses on the hallucinogenic substance Salvia divinorum, the use of which has been observed, particularly among youth worldwide. We present background information based on a review of the literature and on our own clinical encounters, as highlighted by two original case reports. We hypothesize that consumption of Salvia divinorum could be associated with the development of psychotic disorders. We propose that clinicians routinely inquire about the use of Salvia in patients with substance use disorders or psychotic illnesses. More research is required to assess any relationship between Salvia divinorum and psychosis. Additionally, we advocate increased public and medical awareness of this substance and other emerging d...Continue Reading

References

May 1, 1989·Acta Psychiatrica Scandinavica·S AndréassonU Rydberg
Aug 15, 1986·Science·A PfeifferH M Emrich
May 1, 1983·Journal of Ethnopharmacology·L J ValdésA G Paul
Jul 1, 1994·Journal of Psychoactive Drugs·L J Valdés
Oct 1, 1993·Addiction·H D Abraham, A M Aldridge
Jan 5, 2002·Journal of Clinical Psychopharmacology·K R Hanes
Aug 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Bryan L RothRichard B Rothman
Feb 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Louise ArseneaultRobin M Murray
Jul 5, 2005·Acta Psychiatrica Scandinavica·M LambertB G Schimmelmann
Oct 11, 2005·Life Sciences·Thomas E Prisinzano
Oct 15, 2005·The Journal of Pharmacology and Experimental Therapeutics·William A CarlezonBruce M Cohen
Apr 14, 2006·Current Opinion in Psychiatry·Jagadisha Thirthalli, Vivek Benegal
May 12, 2007·Addiction·Sundeep Singh
Aug 21, 2007·Journal of Psychoactive Drugs·Phil Dalgarno
Sep 18, 2007·Pharmacology & Therapeutics·T S ShippenbergV I Chefer
Aug 30, 2008·Journal of Psychoactive Drugs·O Hayden GriffinDavid N Khey
Dec 17, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Toni S Shippenberg
Feb 6, 2009·The Journal of Clinical Psychiatry·Michael Paulzen, Gerhard Gründer
Jul 3, 2009·The American Journal of Psychiatry·Peter Przekop, Timothy Lee
Aug 27, 2009·Organic & Biomolecular Chemistry·Denise S SimpsonThomas E Prisinzano
Dec 17, 2009·Journal of Psychoactive Drugs·Dawn N Albertson, Laura E Grubbs
May 28, 2011·Journal of Psychoactive Drugs·Brian C Kelly
Nov 9, 2012·Psychopharmacology·Katherine A MacLeanRoland R Griffiths
Feb 20, 2013·The Journal of Clinical Psychiatry·Jussi A Niemi-PynttäriSami P Pirkola

❮ Previous
Next ❯

Citations

Mar 30, 2018·The American Journal on Addictions·Joseph El-Khoury, Evelyne Baroud
Oct 31, 2018·Community Mental Health Journal·Antoine KaramFrancois Kazour
Jul 11, 2020·Expert Review of Clinical Pharmacology·Justin P ReinertRebecca L Dunn
Feb 7, 2021·Pharmaceuticals·Andreia Machado Brito-da-CostaÁurea Madureira-Carvalho

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here